Mensch Pharma Private Limited
Pharmaceutical company specializing in manufacturing, importing, and exporting various healthcare products.
2021 | Aurangabad, Maharashtra (India) | Active
Mensch Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 7 Months
About Mensch Pharma
Mensch Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2021 (Three years and seven months 30 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manzoorkhan Khan and Mohommad Syed serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299MH2021PTC362930
- Company No.
362930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Healthcare
Who are the key members and board of directors at Mensch Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manzoorkhan Khan  | Director | 29-Jun-2021 | Current |
| Mohommad Syed | Director | 29-Jun-2021 | Current |
Financial Performance of Mensch Pharma.
Enhance accessibility to Mensch Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mensch Pharma?
Unlock access to Mensch Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Foundgate Infra Private Limited
Manzoorkhan Khan is a mutual person
- Umaya Infra Private Limited
Manzoorkhan Khan is a mutual person
- Ikon Multi Speciality Hospital Private Limited
Mohommad Syed is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mensch Pharma?
Mensch Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mensch Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mensch Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.